SUBSCRIBE
SUBSCRIBE
News   Policy

Ahead of the Bell: FDA to Rule on Eli Lilly and Company Drug

September 26, 2008 | 
1 min read
WASHINGTON - Eli Lilly executives are bracing Friday for a government decision on the company's blood thinner prasugrel, a potential blockbuster drug which regulators already have delayed once.
Regulatory
Eli Lilly and Company Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Success to win in business competition, overcome obstacles or motivation to solve problem and lead company achievement concept, confident businessman leader jump high over 3 hurdles to be winner.
Approvals
KalVista Wins OK for First On-Demand Hereditary Angioedema Pill
July 7, 2025
 · 
2 min read
 · 
Tristan Manalac
Entrance to the U.S. Department of Health and Human Services in Washington, DC
Layoffs
HHS Cuts and Rehires by the Numbers: What We Know About Kennedy’s Overhaul
July 7, 2025
 · 
3 min read
 · 
Tristan Manalac
Close-Up Of Syringe With Bottles Against Blue Background
RSV
Kennedy Follows RSV Recommendations of ACIP Members He Fired
July 3, 2025
 · 
3 min read
 · 
Tristan Manalac
Minimal icon featuring open blue padlock with white upward arrow passing through it, symbolizing security, access, or unlocking new opportunities, digital access, data protection, 3d rendering
Accelerated approval
Regeneron Scores Multiple Myeloma Nod for Bispecific, Unlocking $600M Opportunity
July 3, 2025
 · 
2 min read
 · 
Tristan Manalac